Z. Abbas, H. T. Wally, and F. A. Qureshi, “FDA approves tebentafusp-tebn for unresectable or metastatic uveal melanoma”, J Pak Med Assoc, vol. 73, no. 10, pp. 2127–2127, Sep. 2023.